ADAMANTILLO DERIVATIVES INDUCTORS OF APOPTOSIS AND ITS USE AS ANTICANCERIGEN AGENTS.

摘要

THE PRESENT INVENTION REFERS TO SPECIFIC DERIVATIVES OF THE ADAMANTILO OR THE ADAMANTILO GROUP, WHICH CONTAIN RETINOID COMPOUNDS AND INDUCE APOPTOSIS OF CANCEROSE CELLS. THESE RETINOID DERIVATIVES OF THE ADAMANTILO ARE USEFUL FOR THE TREATMENT OF MANY CANCERES AND SOLID TUMORS, ESPECIALLY THE CANCER OF ANDROGENOINDEPENDENT PROSTATE, THE CANCER DE LEATHER, THE CARCINOMA PANCREATICO, THE CANCER DE COLON, EL CANCER, CANCER CANCER PULMONARY CARCINOMA OF SMALL CELLS, THE PULMONARY CARCINOMA OF NON-SMALL CELLS, THE CERVICAL CARCINOMA, THE CANCER OF BRAIN, THE CANCER OF BLADDER, THE CANCER OF BREAST, THE NEUROBLASTOMA / GLIOBLASTOMA. THE INVENTION ALSO REFERS TO NEW COMPOUNDS DERIVED FROM THE ADAMANTILO OR THE ADAMANTILO GROUP, WHICH ARE USEFUL AS ACTIVE AGENTS FOR THE TREATMENT OR PREVENTION OF QUERATINIZATION DISORDERS AND OTHER DERMATOLOGICAL TABLES, AND OTHER DISEASES.